Fri Jul 3 20:18:39 SGT 2015  
    Hepatitis B, Philippines
HIV PEP (post-exposure prophylaxis): Stop HIV infection within 3 days after unprotected sex.
HIV test: 20 minute rapid test to accurately detect HIV infection 28 days after unprotected sex.
STD testing: Full & comprehensive sexually transmitted disease testing.

Hepatitis B, Philippines


Hepatitis B, Philippines @hepatitisb_biz: Hepatitis B symptoms in men/women, screening/diagnosis, testing/check and treatment, Philippines - Private and confidential service.

Keywords: Hepatitis B Philippines, Philippines Hepatitis B, Hepatitis B.


Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hepatitis B, Philippines
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception (females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing.
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception (females only)
2 weeks HIV DNA PCR test
1 month 20 minute HIV rapid test - SD Bioline HIV Ag/Ab Combo:
- Fingerprick blood sampling.
3 months 20 minute HIV rapid test - OraQuick®:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference

Latest News

Survey of Immunization Practices in Patients With Inflammatory Bowel Disease Among Pediatric Gastroenterologists
Wed, 01 Jul 2015 05:00:00 +0100 | Journal of Pediatric Gastroenterology and Nutrition
Conclusions: There is practice variation among pediatric gastroenterologists in assessment of immunizations in patients with inflammatory bowel disease, including the specific vaccines assessed, and timing and method of assessment. Inability to coordinate care, access immunization records, and offer vaccines through their medical practice are barriers to adhering to immunization guidelines. (Source: Journal of Pediatric Gastroenterology and Nutrition)

A major shift of viral and nutritional risk factors affects the hepatocellular carcinoma risk among Ivorian patients: a preliminary report
Tue, 30 Jun 2015 00:00:00 +0100 | Infectious Agents and Cancer
In conclusion, our work indicates that HCC epidemiology underwent recently major drifts in Ivory Coast. (Source: Infectious Agents and Cancer)

Complement C4a Inhibits the Secretion of Hepatitis B Virus Screened by Surface‐enhanced Laster Desorption Ionization Time‐Flight Mass Spectrometry (SELDI)‐based ProteinChip Analysis
Mon, 29 Jun 2015 00:00:00 +0100 | Proteomics. Clinical Applications
Conclusions and clinical relevance: The present study implied the important role of complement C4a in inhibiting the HBV DNA secretion in CHB.This article is protected by copyright. All rights reserved (Source: Proteomics. Clinical Applications)

Inhibition of microRNA‐214 ameliorates hepatic fibrosis and tumor incidence in platelet‐derived growth factor C transgenic mice
Mon, 29 Jun 2015 00:00:00 +0100 | Cancer Science
In conclusion, miR‐214 appears to participate in the development of hepatic fibrosis by modulating the EGFR and TGF‐β signaling pathways. LNA‐antimiR‐214 may be a potentially therapy in the prevention of hepatic fibrosis.

Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update [ASCO SPECIAL ARTICLES]
Mon, 29 Jun 2015 00:00:00 +0100 | Journal of Clinical Oncology

Chronic hepatitis B: Are we close to a cure?
Mon, 29 Jun 2015 00:00:00 +0100 | Digestive and Liver Disease
Approximately 300 million people worldwide are persistently infected with the hepatitis B virus and are at risk of developing hepatocellular carcinoma and liver cirrhosis, which can progress to end-stage liver disease. Despite the effectiveness of the current vaccination policy, the prevalence of the disease remains high, and the burden for health services is considerable. The currently available antiviral strategies are either poorly effective or only effective for non-curative suppression of viral replication. (Source: Digestive and Liver Disease)

AGA Hepatitis B Virus Reactivation Guideline: Patient Summary
Mon, 29 Jun 2015 00:00:00 +0100 | Gastroenterology
Hepatitis B (HBV) is a virus that affects the liver. Not everyone with HBV will have symptoms when they are infected. HBV will usually go away on its own within 6 months, but sometimes it becomes a long-term (chronic) infection. The DNA of the virus can stay in the body even after the initial infection goes away, and infection may be reactivated under certain conditions. Drugs that weaken the immune system may increase an individual’s risk for HBV reactivation, which can cause life-threatening liver problems. (Source: Gastroenterology)

4'‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus
Mon, 29 Jun 2015 00:00:00 +0100 | Hepatology
Conclusion: These data provide insights on the structural and functional associations of HBV‐ and HIV‐1‐RTs and show that CAdA may offer new therapeutic options for HBV patients. This article is protected by copyright. All rights reserved. (Source: Hepatology)

The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases
Fri, 26 Jun 2015 20:36:01 +0100 | Clinical Chemistry and Laboratory Medicine
Journal Name: Clinical Chemistry and Laboratory Medicine (CCLM)Issue: Ahead of print (Source: Clinical Chemistry and Laboratory Medicine)

Shifting hepatitis B virus genotypes of acute hepatitis B patients in northeast Japan
Fri, 26 Jun 2015 18:40:26 +0100 | Journal of Medical Virology
In conclusion, the percentage of HBV/A in AHB patients has been increasing in northeast Japan since 2001, which is later than metropolitan areas, whereas that of HBV/B is decreasing. This article is protected by copyright. All rights reserved (Source: Journal of Medical Virology)